Long-Term Observation of Adolescents Initiating HAART Therapy: Three-Year Follow-Up-Reference-Cited by-同舟云学术

Long-Term Observation of Adolescents Initiating HAART Therapy: Three-Year Follow-Up

Published:2007-10 Issue:10 Volume:23 Page:1208-1214
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Flynn Patricia M.¹²³,Rudy Bret J.⁴,Lindsey Jane C.⁵,Douglas Steven D.⁴,Lathey Janet⁶,Spector Stephen A.⁷,Martinez Jaime⁸,Silio Margarita⁹,Belzer Marvin¹⁰,Friedman Lawrence¹¹,D'Angelo Lawrence¹²,Smith Elizabeth¹³,Hodge Janice¹⁴,Hughes Michael D.⁵,

Affiliation:

1. Department of Infectious Diseases, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee 38105.

2. Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee 38105.

3. Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38105.

4. Children's Hospital of Philadelphia, Department of Pediatrics, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104.

5. Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115.

6. SeraCare BioServices, Gaithersburg, Maryland 20877.

7. Department of Pediatrics, University of California, San Diego, La Jolla, California 92037.

8. Department of Pediatrics, Stroger Hospital of Cook County/CORE Center, Chicago, Illinois 60612.

9. Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana 70112.

10. Department of Pediatrics, University of Southern California, Los Angeles, California 90033.

11. Department of Pediatrics, University of Miami School of Medicine, Miami, Florida 33136.

12. Children's Hospital, National Medical Center, Washington, D.C. 20010.

13. National Institute of Allergy and Infectious Diseases, Rockville, Maryland 20857.

14. Frontier Science and Technology Research Foundations, Inc., Amherst, New York 14226.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2006.0290

Reference18 articles.

1. A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)‐1 Protease, to Treat HIV Infection

2. A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral Therapy

3. Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

4. Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prednisone for the prevention of tuberculosis-associated IRIS (randomized controlled trial): Impact on the health-related quality of life;Frontiers in Psychology;2022-10-05

2. Data-informed stepped care to improve youth engagement in HIV care in Kenya: a protocol for a cluster randomised trial of a health service intervention;BMJ Open;2022-10

3. Use of Antiretroviral Therapy for a US Medicaid Enrolled Pediatric Cohort with HIV;AIDS and Behavior;2021-03-04

4. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors;PLOS ONE;2020-11-23

5. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020;MMWR. Recommendations and Reports;2020-04-24